Mikko Hiltunen
0000-0003-3566-4096
Publication & Citation Trends
Publications
0 total
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2 OA
Cited by 9
Semantic Scholar
Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process
Cited by 13
Semantic Scholar
Tissue Inhibitor of Metalloproteinase 1 Adenoviral Gene Therapy Alone Is Equally Effective in Reducing Restenosis as Combination Gene Therapy in a Rabbit Restenosis Model
Cited by 19
Semantic Scholar
Intravascular adenovirus-mediated lipoprotein-associated phospholipase A2 gene transfer reduces neointima formation in balloon-denuded rabbit aorta.
Cited by 29
Semantic Scholar
Feline immunodeficiency virus and retrovirus-mediated adventitial ex vivo gene transfer to rabbit carotid artery using autologous vascular smooth muscle cells.
Cited by 9
Semantic Scholar
Oral Imatinib Mesylate (STI571/Gleevec) Improves the Efficacy of Local Intravascular Vascular Endothelial Growth Factor-C Gene Transfer in Reducing Neointimal Growth in Hypercholesterolemic Rabbits OA
Cited by 52
Semantic Scholar
O2582 VEGF-A GENE TRANSFER INDUCES BONE FORMATION
Cited by 0
Semantic Scholar
P3-172 Two complementary methods of protein localization in the cell: a study of the distribution of the muscarinic M2 acetylcholine receptor, and its colocalization with parvalbumin and calretinin, in the rat entorhinal cortex
Cited by 0
Semantic Scholar
Vascular endothelial growth factor-D expression in human atherosclerotic lesions. OA
Cited by 89
Semantic Scholar
ATVB in Focus Smooth Muscle Cells
Cited by 0
Semantic Scholar
Research Topics
Alzheimer's disease research and treatments
(121)
Cerebrospinal fluid and hydrocephalus
(31)
Genetic Associations and Epidemiology
(29)
Neuroinflammation and Neurodegeneration Mechanisms
(29)
Traumatic Brain Injury and Neurovascular Disturbances
(23)
Affiliations
Broad Institute
Boston University
Yamagata University
Uppsala University
Novartis (Switzerland)